One Africa, One Market - Join Zandaux to unlock your potential

Become a Merchant

Welcome To Zandaux-developer

  • Vendor login
  • Track Your Order
  • Support
Dynapharmverified-badge
Quality Yeeyangyen Tablet 30S-MoQ 1 Packet #Wholesale#Bulk#Kenya
KES 3,100.00

USD 20.97

USD 20.97

Availability:
In Stock
Condition:
New
Shipping
Estimate:
MoQ:
PACKAGE 222 in stock
Total Items:
Calculating
Total Amount:
Will be calculated after you select all properties
Buy Now Add to Cart
Logo Kenya

Key Features

  • Minimum Order Quantity 1 Packet
  • Relieves dry skin
  • Reduce risk of cancer
  • Ant-ageing
  • Improves circulation helps reduce excessive blood sugar
  • Prevents stroke and heart attack
  • Delivery within 1- 2 days

CONTENTS: Extracted from grape seeds from Italy Content of Oligomeric Proanthocyanidins (OPC) is more than 95% . Strong antioxidant properties . Antimutagenic . Improves the biochemical properties of blood vessels . . Anti ageing . Strengthens collagen to help improve the elasticity and youthfulness of the skin . Heals wounds and diminishes scars . Relieves dry skin. . Neutralizes free radicals. . Reduces risk of cancer. . Prevents and relieves allergies . Strengthens the cardiovascular system. . Prevents vascular and cerebral accidents such as stroke and heart attacks. . Improves circulation and helps reduce excessive blood sugar. . Prevents stress and reduces fatigue. . Prevents arthritis, phlebitis and vericose veins . Prevents liver and kidney disease


Technical Details:

Brand: Dynapharm
Seller SKU: 477
Condition: New
Availability: In Stock
Minimum order quantity: 1
Date first listed on Zandaux-developer : Jul 31, 2023
  • Relieves dry skin 
  • Reduce risk of cancer 
  • Ant-ageing 
  • Improves circulation helps reduce excessive blood sugar
  • prevent stress and reduce fatigue 
  • prevent arthritis phlebitis and varicose
CONSUMPTION
  • Consume 2 tablets,twice a day 
  • Before meals   

No reviews

busy...
Dynapharm
DYNAPHARM (Online)

We're just one step away! Please login to start the conversation. Login